InvestorsHub Logo

BTH

Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: wrkingcapital post# 2530

Thursday, 10/14/2010 7:55:53 PM

Thursday, October 14, 2010 7:55:53 PM

Post# of 80490
I just think 4.00 is a round number with a lot of resistance at that level - - - and - - - there is absolutely no news to give new investors, day traders, or position traders a reason to get involved in the name. The company has at least 5-7 open Ridaforolimus trials going right now, and they had nothing to speak about, whatsoever, at ESMO (other than a hidden abstract which they did nothing with). ASCO was a snoozefest for Ariad. It seems just about every oncology conference, Afinitor (everolimus) has several data presentations to Ridaforolimus' zero.

Hopefully the endometrial trial is actually PR'd and well received. However, because I actually think it is important, it probably will be a non-event. LOL.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.